MANUEL
CAMPOS TOIMIL
Profesor titular de universidade
Instituto de Salud Carlos III
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (3)
2023
-
The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats
Biomedicine and Pharmacotherapy, Vol. 161
-
Vessel-on-a-Chip: A Powerful Tool for Investigating Endothelial COVID-19 Fingerprints
Cells, Vol. 12, Núm. 9